高迁移率族蛋白B1在香烟暴露大鼠模型中的表达及其意义
摘要
研究背景:慢性支气管炎(chronic bronchitis)是一种全球性患病率和死亡率很高而病因及发病机制尚不完全清楚的疾病,严重危害着中老年患者的健康,目前认为是一种可防可治的疾病。危险因素包括吸烟、粉尘、刺激性气体、感染、免疫、年龄、气候等,其中吸烟是引起慢性支气管炎发生、发展的最主要等危险因素。烟熏法复制慢性支气管炎动物模型的研究已有成功应用。高迁移率族蛋白B1(high mobility group box-1 protein,HMGB1)是一种普遍存在的高度保守的核蛋白,参与DNA的转录、复制、修复以及炎症反应等。正常情况下,人类和大鼠气道内即有一定水平HMGB1表达,对呼吸系统正常功能的维持具有重要作用。在肺组织中, HMGB1具有促炎细胞因子的作用,是介导急性肺部炎症反应重要的生物学介质。HMGB1可作为一种晚期重要的炎症因子参与对炎症的调控作用,在肺损伤、肺癌、肺纤维化、COPD等肺部疾病中已有大量研究,但HMGB1在大鼠慢性支气管炎模型中的作用尚无报道。因此本研究用烟熏法模拟人类慢性支气管炎的发病过程拟检测HMGB1在大鼠模型中的表达,初步探讨HMGB1在慢性支气管炎中的作用。
目的:通过烟熏法建立大鼠慢性支气管炎模型,检测大鼠模型肺组织及血清中HMGB1的表达情况,比较HMGB1在模型组与对照组两组之间的差别,初步探讨HMGB1在香烟诱导的慢性支气管炎大鼠模型中的作用。
方法:将雄性SD大鼠随机分为正常对照组、吸烟模型组,每组14只。模型组大鼠置于自制密闭烟熏箱内进行被动吸烟,每天烟熏2次,每次14支,烟熏30min ,烟雾浓度约5%(v / v),两次之间相隔不少于4 h ,每周被动吸烟6d ,连续75 d,对照组正常饲养,不作上述处理,建立慢性支气管炎大鼠模型。模型成功后,光镜下观察支气管肺组织病理形态学改变,分析支气管肺泡灌洗液(BALF)细胞计数和分类,用ELISA法检测大鼠血清中HMGB1的浓度,免疫组化法检测HMGB1在肺组织中的表达。
结果:模型组大鼠肺组织的病理形态改变与人类慢性支气管的特点相一致。模型组和健康对照组大鼠BALF的细胞总数、单核巨噬细胞及中性粒细胞百分比分别为(5.12±0.69×108/L、69.62±4.82%、22.62±2.47%;1.79±0.19×108/L、86.00±2.45%、7.71±1.27%),两组相比差异有显著性意义( P < 0.05)。说明慢性支气管炎大鼠模型是成功的。模型组与对照组血清中HMGB1分别为(2.41±0.31 ug/L,1.60±0.16 ug/L),与对照组相比,模型组大鼠血清HMGB1的含量显著升高( P < 0.05)。对大鼠肺组织进行免疫组化染色观察HMGB1的表达,可见HMGB1主要分布于支气管及肺泡上皮细胞,与对照组比较,模型组大鼠肺组织HMGB1的表达强度明显增强,用图形分析软件对染色结果进行分析,测量并记录每个视野HMGB1的阳性染色的平均积分光密度值( IOD) ,模型组与对照的IOD)进行比较,有显著性差异( P < 0.05)。
结论:1.与对照组相比,模型组大鼠血清HMGB1的含量显著升高。
2. HMGB1主要分布于支气管及肺泡上皮细胞,与对照组比较,模型组大鼠肺组织HMGB1的表达强度明显增强。
3.模型大鼠的肺组织及血清HMGB1的表达显著高于对照组,结果均有统计学意义,这说明HMGB1在慢性支气管炎的大鼠模型中起到一定的作用,但其调控机制尚需深入研究。
Research background:chronic bronchitis is a disease that the etiological factor and pathogenesis are not understood entirely,endangering seriously the health of elderly patients,and it is a preventable,treatable disease currently. Smoking is one of the marjor risk factors for the development of chronic bronchitis besides dust,irritating,gases ,infection,immunication,age,climate.It has been applied successfully that replicated animal model of chronic bronchitis with smoking. High mobility group box-1 protein is a highly conserved prevalent nuclear protein ,it participates in DNA transcription, replication, repairment and inflammatory reactions. It is found that a certain level of HMGB1 expressed in both the human and rat airways . HMGB1 plays an important role in maintaining the normal function of the respiratory system. HMGB1 has a role of proinflammatory cytokines in lung tissue,it mediated important acute lung inflammation biological mediator. As a late inflammatory cytokines,HMGB1 playes an important regulatory role of inflammation,There have been many research reports of HMGB1 in lung injury, lung cancer, pulmonary fibrosis and other lung diseases, but few on COPD . However,there is no report on the role of HMGB1 in chronic bronchitis. This study established a rat model of human chronic bronchitis with smoking and detected the HMGB1 expression ,discussing the role of HMGB1 in chronic bronchitis.
Objective:By establishing the rat model of chronic bronchitis, detecting rat model expression of HMGB1 in lung tissue and serum and comparing the expression of HMGB1 between the model group and the control group to reveal the role of HMGB1 of chronic bronchitis in rat model induced by smoking.
Methods:The male SD rats were randomly divided into normal control group and smoking model group, 14 rats in each group. Model rats were placed inside the homemade sealed box for passive smoking,smoking 2 times a day with an interval longer than 4 h, 14 sigerates each time for 30 minutes,the concentration of smog is about 5% (v / v), Six days per week,continuously for 75 days. The lung tissue section stained by HE was observed under optical microscope in order to study the alternation of histopathologic.Total cell counts and differential analysis in BALF were performed.The concentrations of HMGB1 in serum were detected by ELISA,The expression of HMGB1 in the lung tissue was detected by immunohistochemical method .
Results:The athological changes in smoking model group were consistent with that of chronic bronchitis.The total cell counting, mononuclear macrophage and neutrophil percentage In BALF were 5.12±0.69×108/L、69.62±4.82%、22.62±2.47%;1.79±0.19×108/L、86.00±2.45%、7.71±1.27% in two groups respectively with significant differences between the smoking model group and normal control group ( P < 0.05). The concentrations of HMGB1 in serum were 2.41±0.31 ug/L,1.60±0.16 ug/L in model group and normal control group respectively indicating that HMGB1 in the model group significantly increased compared with the control group (P <0.05). HMGB1 was found in the bronchial and alveolar epithelial cells , it increased significantly tban that the expression intensity of HMGB1 in model group lung tissue,using graphical analysis software to analysis of staining results, measuring and recording the positive staining of HMGB1 per field, the average integrated optical density (IOD) of the model group and the control,the expressions of HMGB1 in the lungs was obviously elevated in the model group(P <0.05).
Conclusions:1. The concentrations of HMGB1 in serum in the model group significantly increased as compared with the control group.
2. HMGB1 was found in the bronchial and alveolar epithelial cells, compared with the control group, the expressions of HMGB1 in the lungs was obviously elevated in the model group.
3. The expressions of HMGB1 in the lungs and the concentrations of HMGB1 in serum in the model group significantly increased as compared with the control group,the results were statistically significant,HMGB1 may play a role in the pathogenesis of chronic bronchitis,but the exact mechanism needs further investigation.
目的:通过烟熏法建立大鼠慢性支气管炎模型,检测大鼠模型肺组织及血清中HMGB1的表达情况,比较HMGB1在模型组与对照组两组之间的差别,初步探讨HMGB1在香烟诱导的慢性支气管炎大鼠模型中的作用。
方法:将雄性SD大鼠随机分为正常对照组、吸烟模型组,每组14只。模型组大鼠置于自制密闭烟熏箱内进行被动吸烟,每天烟熏2次,每次14支,烟熏30min ,烟雾浓度约5%(v / v),两次之间相隔不少于4 h ,每周被动吸烟6d ,连续75 d,对照组正常饲养,不作上述处理,建立慢性支气管炎大鼠模型。模型成功后,光镜下观察支气管肺组织病理形态学改变,分析支气管肺泡灌洗液(BALF)细胞计数和分类,用ELISA法检测大鼠血清中HMGB1的浓度,免疫组化法检测HMGB1在肺组织中的表达。
结果:模型组大鼠肺组织的病理形态改变与人类慢性支气管的特点相一致。模型组和健康对照组大鼠BALF的细胞总数、单核巨噬细胞及中性粒细胞百分比分别为(5.12±0.69×108/L、69.62±4.82%、22.62±2.47%;1.79±0.19×108/L、86.00±2.45%、7.71±1.27%),两组相比差异有显著性意义( P < 0.05)。说明慢性支气管炎大鼠模型是成功的。模型组与对照组血清中HMGB1分别为(2.41±0.31 ug/L,1.60±0.16 ug/L),与对照组相比,模型组大鼠血清HMGB1的含量显著升高( P < 0.05)。对大鼠肺组织进行免疫组化染色观察HMGB1的表达,可见HMGB1主要分布于支气管及肺泡上皮细胞,与对照组比较,模型组大鼠肺组织HMGB1的表达强度明显增强,用图形分析软件对染色结果进行分析,测量并记录每个视野HMGB1的阳性染色的平均积分光密度值( IOD) ,模型组与对照的IOD)进行比较,有显著性差异( P < 0.05)。
结论:1.与对照组相比,模型组大鼠血清HMGB1的含量显著升高。
2. HMGB1主要分布于支气管及肺泡上皮细胞,与对照组比较,模型组大鼠肺组织HMGB1的表达强度明显增强。
3.模型大鼠的肺组织及血清HMGB1的表达显著高于对照组,结果均有统计学意义,这说明HMGB1在慢性支气管炎的大鼠模型中起到一定的作用,但其调控机制尚需深入研究。
Research background:chronic bronchitis is a disease that the etiological factor and pathogenesis are not understood entirely,endangering seriously the health of elderly patients,and it is a preventable,treatable disease currently. Smoking is one of the marjor risk factors for the development of chronic bronchitis besides dust,irritating,gases ,infection,immunication,age,climate.It has been applied successfully that replicated animal model of chronic bronchitis with smoking. High mobility group box-1 protein is a highly conserved prevalent nuclear protein ,it participates in DNA transcription, replication, repairment and inflammatory reactions. It is found that a certain level of HMGB1 expressed in both the human and rat airways . HMGB1 plays an important role in maintaining the normal function of the respiratory system. HMGB1 has a role of proinflammatory cytokines in lung tissue,it mediated important acute lung inflammation biological mediator. As a late inflammatory cytokines,HMGB1 playes an important regulatory role of inflammation,There have been many research reports of HMGB1 in lung injury, lung cancer, pulmonary fibrosis and other lung diseases, but few on COPD . However,there is no report on the role of HMGB1 in chronic bronchitis. This study established a rat model of human chronic bronchitis with smoking and detected the HMGB1 expression ,discussing the role of HMGB1 in chronic bronchitis.
Objective:By establishing the rat model of chronic bronchitis, detecting rat model expression of HMGB1 in lung tissue and serum and comparing the expression of HMGB1 between the model group and the control group to reveal the role of HMGB1 of chronic bronchitis in rat model induced by smoking.
Methods:The male SD rats were randomly divided into normal control group and smoking model group, 14 rats in each group. Model rats were placed inside the homemade sealed box for passive smoking,smoking 2 times a day with an interval longer than 4 h, 14 sigerates each time for 30 minutes,the concentration of smog is about 5% (v / v), Six days per week,continuously for 75 days. The lung tissue section stained by HE was observed under optical microscope in order to study the alternation of histopathologic.Total cell counts and differential analysis in BALF were performed.The concentrations of HMGB1 in serum were detected by ELISA,The expression of HMGB1 in the lung tissue was detected by immunohistochemical method .
Results:The athological changes in smoking model group were consistent with that of chronic bronchitis.The total cell counting, mononuclear macrophage and neutrophil percentage In BALF were 5.12±0.69×108/L、69.62±4.82%、22.62±2.47%;1.79±0.19×108/L、86.00±2.45%、7.71±1.27% in two groups respectively with significant differences between the smoking model group and normal control group ( P < 0.05). The concentrations of HMGB1 in serum were 2.41±0.31 ug/L,1.60±0.16 ug/L in model group and normal control group respectively indicating that HMGB1 in the model group significantly increased compared with the control group (P <0.05). HMGB1 was found in the bronchial and alveolar epithelial cells , it increased significantly tban that the expression intensity of HMGB1 in model group lung tissue,using graphical analysis software to analysis of staining results, measuring and recording the positive staining of HMGB1 per field, the average integrated optical density (IOD) of the model group and the control,the expressions of HMGB1 in the lungs was obviously elevated in the model group(P <0.05).
Conclusions:1. The concentrations of HMGB1 in serum in the model group significantly increased as compared with the control group.
2. HMGB1 was found in the bronchial and alveolar epithelial cells, compared with the control group, the expressions of HMGB1 in the lungs was obviously elevated in the model group.
3. The expressions of HMGB1 in the lungs and the concentrations of HMGB1 in serum in the model group significantly increased as compared with the control group,the results were statistically significant,HMGB1 may play a role in the pathogenesis of chronic bronchitis,but the exact mechanism needs further investigation.
引文
1. H allberg J, Dom inicusA, E riksson UK, et a.l Interaction betw een smoking and genet ic factors in the development of chron ic bronch it is[ J]. American journal o f resp iratory and critical care medicine, 2008, 177( 5) : 486- 490.
2. Cosio MG,Hale KA ,Niewoehner M,et al . Morphologic and morphometric effects of prolonged cigarette smoking on the small airways[J ] . Am Rev Respir Dis ,1980 ,122 (2) :205～221.
3.马鸿达,张乃鑫,赵天如,等.吸烟者肺泡接触段破坏及其小气道形态异常的关系[J ] .中华病理学杂志,1996 ,25 (4) :216～219.
4.马鸿达,张乃鑫,祝尔诚.吸烟肺小气道形态计量学及其与肺气肿类型的关系[J ] .天津医学,1995 ,23 (8) :451～455.
5.叶任高.内科学[M ] .第5版.北京:人民卫生出版社, 2001. 15- 18.
6.周汉良,陈季强.呼吸药理学与治疗学[M ].北京:人民出版社,1998: 912.
7. Hansel TT, Barnes PJ. New D rugs fo r A sthma, A llergy and COPD [M ]. Basel: ProgRespir Res, 2001: 160 - 164.
8. Thorburn J, Frankel AE, Thorburn A. Regulation of HMGB1 release by autophagy. Autophagy, 2009, 5: 247-249.
9. Bustin M, Lehn DA, Landsman D. Structural features of the HMG chromosomal proteins and their genes. Biochim Biophys Acta 1990;1049:231e43.
10.Andersson U, Erlandsson-Harris H, Yang H, Tracey KJ. HMGB1 asa DNA-binding cytokine. J Leukoc Biol 2002;72:1084e91.
11. Wang H , Bloom O , Zhang M , et al . HMGB1 as a late mediator of endotoxin lethality in mice. Science , 1999 , 285 (5425) : 248-251.
12. Stros M, Bacikova A, Polanska E, et al.HMGB1 interacts with humantopoisomerase IIalpha and stimulates its catalytic activity [J].NucleicAcids Res, 2007, 35(15): 50013.
13. Coffey JC,Wang JH, Kelly R, et al.Tolerization with BLP down- regulates HMGB1 a critical mediator of sepsis- related lethality [J]. JLeukoc Biol, 2007, 82(4): 906.
14. Holmlund U,Wahamaa H, Bachmayer N, et al.The novel inflammatory cytokine high mobility group box protein 1 (HMGB1) is expressed by human term placenta[J].Immunology, 2007, 122(3):430.
15. Rauvala H, Rouhiainen A. RAGE as a recep tor of HMGB1 (Am-photerin) : roles in health and disease [ J ]. CurrMolMed, 2007, 7(8) : 725-734.
16. Yang H,Wang H, Czura CJ, et al. The cytokine activity of HMGB1[ J ]. J Leukoc Biol, 2005, 78 (1) : 128
17. Bianchi ME , Manf redi AA. High2mobility group box 1( HMGB1) protein at t he crossroads between innate and adaptive immunity [J ] . Immunol Rev , 2007 ,220 : 35246.
18. BianchiME, Manfredi AA. Immunology. Dangers in and out[ J ]. Science, 2009, 323 (5922) : 1683 - 1684.
19. Klune JR, Dhupar R, Cardinal J , et al. HMGB1: endogenous danger signaling[ J ]. MolMed, 2008, 14 (7 - 8) : 476- 484.
20. Karlsson S, Pettil?V, Tenhunen J , et al. HMGB1 as apredictor of organ dysfunction and outcome in patientswith severe sepsis[ J ]. Intensive CareMed, 2008, 34 (6) : 1046-1053.
21. Abraham E, Arcaroli J, CarmodyA, et al. HMG21 as a mediator of acute lung Inflammation [ J ]. The Journal of Immunology, 2000,165 (6) : 2950-2924.
22. Kokkola R,Andersson A,Mullins G, et al. RAGE is the major recep tor for the p roinflammatory activity of HMGB1 in rodentmacrophages[ J ]. Scand Immunol, 2005, 61 (1) : 129.
23. Orlova VV, Choi EY, Xie CP, et al. A novel pathway of HMGB1 mediated inflammatory cell recruitment that requiresMac-1-integrin[ J ]. EMBO, 2007, 26 (4) : 112921139.
24. Fan J, Li Y, Levy RM, et al. Hemorrhagic shock induces NAD ( P) H oxidase activation in neutrophils: role of HMGB1-TLR4signaling[ J ]. J Immunol, 2007, 178 (10) : 657326580.
25. Yang H , Wang H , Czura CJ , et al . The cytokine activity of HMGB1. J Leukoc Biol , 2005 , 78 (1) : 128.
26. Gong Q, Xu JF , Yin H, et al. Protective Effect of Antagonist of High-mobility Group Box 1 on Lipopolysaccharide-Induced Acute Lung Injury in Mice[J]. Scandinavian Journal of Immunology ,2009,69(1):29–35.
27. Guan-Hong Shang , Chong-Qi Jia ,Hui Tian,et al. Serum high mobility group box protein 1 as a clinical marker for non-small cell lung cancer [J]. Respiratory Medicine ,2009,103(12):1949-1953.
28. KakizakiT, Kohno M, Watenabe M, et al.Exacerbation of Bleomycin-Induced Injury and Fibrosis by Pneumonectomy in the Residual Lung of Mice[J]. Journal of Surgical Research ,2009,154(2):336–344 .
29. Ferhani N, Letuve S, Kozhich A, et al. Expression of high-mobility group box 1 and of receptor for advanced glycation end products in chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 2010,181(9):917-927.
30. Karlsson S ,Pettil?V ,Tenhunen J ,et al . HMGB1 as a predictor of organ dysfunction and outcome in patients with severe sepsis[J ] . Intensive Care Med ,2008 ,34 (6) :1046.
31.陈国千,胡志刚,王春新,等.外科术后患者血清HMGB1水平的变化及其意义[J] .中华临床医师杂志(电子版) ,2009 ,3 (3) :478.
32.曾玉兰,杨荣时,彭红星.盐酸氨溴索对吸烟诱导的支气管炎大鼠MIP- 2的影响[J].中国现代医学杂,2009,19(17):2585-2587.
33.李莉,王向东.糖皮质激素抑制慢性支气管炎大鼠气道磷酸二酯酶4D和肿瘤坏死因子α的表达[J].中国呼吸与危重监护杂志,2009,8(6):534-538.
34.冯正仪主编.内科护理学[M ].上海:上海科学技术出版社,2002: 9, 12.
35. Sherrill DL, Holberg CJ, Enright PL, et al. Longitudinal analysis of the effects of smoking onset and cessation on pulmonary function.Am J Resp ir Crit CareMed, 1994, 149: 591-597.
36.邬强珍.浅谈老年慢性支气管炎病人的健康教育指导[ J ].中国全科医学, 1999, 2 (4) :321.
37.潭壮生.吸烟和饮酒现状及其危害和对策[J].中国全科医学, 2006 ,9(13):1082-1084.
38.Zhang H ,Cai B. The impact of tobacco on lung health in China Respirology ,2003 ,8 :17-21.
39.李爱兰,黄悦勤,王燕玲,等.我国青少年吸烟行为及其影响因素的初步分析[J].中国公共卫生, 2001, 17(1): 75-77.
40.杨功焕. 1996年全国吸烟行为的流行病学调查[M].北京:中国科学技术出版社, 1997: 17-18.
41. D'Armiento J, Dalal SS, Okada Y, et al. Collagenase exprssion in the lungs of transgenic mice cause pulmonary emphysema. Cell 1992;71(6):955-961.
42. Chung KF. Inflammatory mediators in chronic obstructive pulmonary disease. Curr Drug Targets Inflamm Allergy 2005;4(6):619-625
43. Chung KF. Cytokines as targets in chronic obstructive pulmonary disease. Curr Drug Targets 2006;7(6):675-681
44. Chung KF. Cytokine in chronic obstructive pulmonary disease. Eur Respir J Suppl 2001;34:50s-59s
45. Stockley RA. Neutrophils and the pathogenesis of COPD. Chest 2002 ;121(5uppl):151s-155s
46. Hallberg J, Dominicus A, Eriksson UK,et al. Interaction Between Smoking andGenetic Factors in the Development of Chronic Bronchitis.Am J Respir Crit Care Med 2007; 2008;177(5):486-490.
47. Hasegawa M,Nasuhara Y,Onodera Y,et al . Airflow limitation and airway dimensions in chronic obstructive pulmonary disease[J ] . AmJ Respir Crit Care Med ,2006 ,173 (12) :1309 - 1315.
48. Ellerman JE, Brown CK, de Vera M, et al. Masquerader: high mobility group box-1 and cancer [ J ]. Clin Cancer Res, 2007, 139(10) : 2836-2848
49. MacNeeW, Donaldson K. Exacerbations of COPD: environmentalmechanisms [J]. Chest, 2000, 117 (5) : 390 -397.
50. MacNee W. Oxidants/Antioxidants and COPD. CHEST, 2000, 117:303-317.
51. Barnes PJ, Shap iro SD, PauwelsRA. Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Resp ir J, 2003, 22:672-688.
52.李庆云,黄绍光,吴华成,等.大鼠吸烟致慢性支气管炎模型气道炎症研究[J].上海第二医科大学学报, 2004, 1: 31.
53.王慧,程德云,张永,等.单核细胞趋化蛋白1在熏香烟大鼠气道表达及泼尼松对其的影响[ J ].中华结核和呼吸杂志, 2004, 27(7) : 490.
54. Dumit riu IE , Baruah P , Manf redi AA , et al . HMGB1 :guiding immunity from wit hin [ J ] . Trends Immunol ,2005 ,26 :3812387
55. Huttunen HJ , Rauvala H. Amphoterin as an extracellular regulator of cell motility: from discovery to disease[J ]. J InternM ed , 2004, 255 (3) : 351-366.
56. Bianchi ME , Manf redi AA. High-mobility group box 1( HMGB1) protein at the crossroads between innate and adaptive immunity [J] . Immunol Rev , 2007 ,220 : 35-46.
57.杨廷芳,王兴勇,胡语航. NF-κB和HMGB1在大鼠肠缺血再灌注肺损伤中的表达及白藜芦醇苷的保护作用.重庆医科大学学报,2009,34(1):24-28.
58. Yang H, OchaniM, Li J, et al1 Reversing established sepsis with antagonists of endogenous highmobility group box 1[ J ]1 Proc Natl Acad Sci USA, 2004, 101( 1) : 296-301.
59. Lotze MT, Tracey KJ1 High2mobility group box 1 protein(HMGB1) : nuclear weapon in the immune arsenal [ J ] .Nat Rev Immunol, 2005, 5 ( 4) : 331-342.
60. Pisetsky DS, Jiang W.Role of Toll- like receptors in HMGB1 release fromacrophages[J].Ann N Y Acad Sci, 2007, 1109:58.
61. Fossati S, Chiarugi A.Relevance of high- mobility group protein box 1 to neurodegeneration[J].Int Rev Neurobiol, 2007, 82: 137.
62. Kalinowska-Herok M, Widlak P. High mobility group proteins stimulate DNA cleavage by apoptotic endonuclease DFF40/CAD due to HMG-box interactions with DNA [J]. Acta Biochim Pol, 2008, 55(1): 21-26.
63. Herold K, Moser B, Chen Y, et al. Receptor for advanced glycation end products (RAGE) in a dash to the rescue: inflammatory signals gone awry in the primal response to stress [J]. J Leukoc Biol, 2007, 82 (2) : 204-212
64. Park JS, Svetkauskaite D, He Q, et al1 Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein1J Biol Chem, 2004, 279 (9) : 7370-7377
65. Gardella S, Andrei C, Ferrera D, Lotti LV, Torrisi MR, Bianchi ME,Rubartelli A. The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway. EMBO Rep 2002;3:995–1001.
66. Bonaldi T, Talamo F, Scaffidi P, Ferrera D, Porto A, Bachi A, Rubartelli A, Agresti A, Bianchi ME. Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. EMBO J 2003;22:5551–5560.
67. Park JS, Svetkauskaite D, He Q, Kim JY, Strassheim D, Ishizaka A,Abraham E. Involvement of Toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem 2004;279:7370–7377.
68.Lotze MT,Tracey KJ.High-mobility group box 1 protein (HMGB1):nuclearweaponin the immune arsenal.NatRevImmunol 2005;5:331–342.
69. Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature, 2002, 418(6894) :191-195
70 .Dumitriu I E ,Baruah P ,Valentinis B et al . Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products[J ] . J Immunol ,2005 ;174 :7506-7515.
71. Jiang W,Pisetsky D S. Mechanisms of Disease :the role of high mobility group protein 1 in the pathogenesis of inflammatory arthritis[J ] . Nat Clin Pract Rheumatol ,2007 ;3 (1) :52258.
72. Sha Y, Zmijewski J , Xu Z, et al. HMGB1 develops enhanced p roinflammatory activity by binding to cytokines[ J ]. J Immunol, 2008, 180 (4) : 2531 - 2537.
73. Park JS, Arcaroli J, Yum HK, Yang H, Wang H, Yang KY,Choe KH, Strassheim D, Pitts TM, Tracey KJ, Abraham E.Activation of gene expression in human neutrophils by high mobility group box 1 protein. Am J Physiol Cell Physiol 2003;284: C870-C879
74. Chen G, Ward MF , Sama AE , et al . Ext racellular HMGB1 as a proinflammatory cytokine. J Interferon Cytokine Res , 2004 , 24(6) : 329-333.
75. Andersson U, Wang H, Palmblad K, et al1High mobility group1 protein (HMG21 ) stimulates p roinflammatory cytokine synthesis in human monocytes1J Exp Med, 2000, 192 (4) : 565-5701.
76. Park JS, Arcaroli J, Yum HK, et al1Activation of gene exp ression in human neutrophils by high mobility group box 1 p rotein1Am J Physiol Cell Physiol, 2003, 284 (4) : C87028791
77. MessmerD, Yang H, Telusma G, et al1High mobility group box p rotein1:anendogenous signal for dendritic cell maturation and Th1 polarization1J Immunol, 2004, 173 (1) : 30723131
78. Czura C J , Tracey KJ . Targeting high mobility group box 1 as a late-acting mediator of inflammation. Crit Care Med , 2003 , 31 (1) : S46～50
79. Yang H , Wang H , Czura C J , Tracey KJ . HMGB1 as a cytokine and therapeutic target . J Endotoxin Res , 2002 , 8 (6) : 469～472
80. Andersson U , Erlandsson2Harris H , Yang H , Tracey KJ . HMGB1 as a DNA2binding cytokine. J Leukoctyte Biol , 2002 , 72 (6) :1084～1091
81.秦阳华,戴生明等.高迁移率族蛋白1促进巨噬细胞表达IL-18及其受体[J].第二军医大学学报,2009,30(12):1353-1356.
82. Klune JR, Dhupar R, Cardinal J, et al. HMGB1: endogenous danger signaling[ J ]. MolMed, 2008, 14: 4762484.
83. Degryse B, Virgilio M. The nuclear protein HMGB1, anew kind of chemokine ?. FEBS Lett, 2003, 553 (122):11-17.
84. Wang H , Ward MF, Fan XG, et al. Potential role of high mobility group box1 in viral infectious diseases . Viral Immunol, 2006, 19 (1) :3-9.
85. Lin X, Yang H, Sakuragi T, et al1 Alpha2chemokine recep tor blockade reduce high mobility group box 1 protein induced lung inflammation and injury and imp roves survivalin sepsis [ J ]1 Am J Physiol Lung CellMol Physiol, 2005,289 ( 4) : 583-590.
86. Yang H , Ochani M , Li J, et al. Reversing established sepsis with antagonists of endogenous high mobility group box 1. Proc Natl Acad Sci USA , 2004 , 101 (1) : 296-301.
87. Ulloa L , Ochani M Yang H, et al. Ethylpyruvate prevents lethality in mice with established lethal sepsis and systemic inflatammation.Proc Natl Acad Sci USA 2002,,9(19):12351-12356.
88. Zhi-Yong Yang, Yan Ling, Tao Yin,etl. Delayed ethylpyruvate therapy attenuates experimental severe acute pancreatitis vis reduced serum high mobility group box 1 levels in rats.World J Gastroenterol。2008,14(28):4546-4550.
89. Abraham E, Arcaroli J, CarmodyA, et al1 HMG21 as a mediator of acute lung inflammation [ J ] 1 J Immunol, 2000,165 ( 6) : 2950-2954
90. Gong Q, Xu JF , Yin H,et al. Protective Effect of Antagonist of High-mobility Group Box 1 on Lipopolysaccharide-Induced Acute Lung Injury in Mice [J]. Scandinavian Journal of Immunology ,2009,69(1):29–35.
91. Yasuda T, Ueda T, Takeyama Y, et al. Significant increase of serum high-mobility group box chromosomal p rotein 1 levels in patients with severe acute pancreatitis[ J ]. Pancreas, 2006, 33: 3592363.
92. Sawa H, Ueda T, Takeyama Y, et al. Blockade of high mobility group box-1 protein attenuates experimental severe acute pancreatitis [ J ].World J Gastroenterol, 2006, 12: 7666-7670.
93. Yang ZY,Ling Y, Yin T, et al. Delayed ethyl pyruvate therapy attenuates experimental severe acute pancreatitis via reduced serum high mobility group box
1 levels in rats [ J ]. World J Gastroenterol, 2008,14: 4546-4550.
94. Agnello D et al . Cytokine , 2002 , 18 (4) : 231—236
95. Abraham E et al . J Immunol , 2000 , 165 (6) : 2950—2954
96. Elwing J, Panos RJ. Pulmonary hypertension associated with COPD. Int J Chron Obstruct Pulmon Dis, 2008, 3(1): 55-70.
97. Wang H , Bloom O , Zhang M , et al . HMGB1 as a late mediator of endotoxin lethality in mice. Science , 1999 , 285 (5425) : 248-251.
98. Chen G, Ward MF , Sama AE , et al . Extracellular HMGB1 as a proinflammatory cytokine. Interferon Cytokine Res , 2004 , 24(6) : 329-333.
99. Taniguchi N , Kawahara K, Yone K, et al . High mobility group box chromosomal protein pay a role in the pathogenesis of rheumatoid as a novel cytokine.Arthritis Rheum,2003,48(4):971-981.
100 . Churg A, Zho u S, Wang X, et al. The role of interleukin-1beta in murine cigarette smoke-induced emphysema and small airway remodeling[J]. Am J Respir Cell Mol Biol,2009,40(4):482-490.
101. Dumit riu IE , Baruah P , Manf redi AA , et al . HMGB1 :guiding immunity f romwithin [J] . Trends Immunol ,2005 ,26(7) :381-387.
102. Wang H ,Ward MF , Fan XG,et al. Potential role of high mobility group box 1 in viral infectious diseases[J ] . Viral Immunol ,2006 ,19 (1) :3-9.
1. Wang H , Bloom O , Zhang M , et al . HMGB1 as a late mediator of endotoxin lethality in mice. Science , 1999 , 285 (5425) : 248-251.
2. Yang H , Wang H , Czura CJ , et al . The cytokine activity of H MGB1. J Leukoc Biol , 2005 , 78 (1) : 1-8.
3. Stros M, Bacikova A, Polanska E, et al.HMGB1 interacts with human topoisomerase IIalpha and stimulates its catalytic activity [J].Nucleic Acids Res, 2007, 35(15): 5001-5013.
4. Bianchi ME , Manf redi AA. High-mobility group box 1( HMGB1) protein at the crossroads between innate and adaptive immunity [J] . Immunol Rev , 2007 ,220 : 35-46.
5. Bianchi ME , Manf redi AA. High2mobility group box 1( HMGB1) protein at t he crossroads between innate and adaptive immunity [J ] . Immunol Rev , 2007 ,220 : 35-46.
6. Agnello D et al . Cytokine , 2002 , 18 (4) : 231—236
7. Herold K, MoserB, Chen Y, et al. Recep tor for advanced glycation end products (RAGE) in a dash to the rescue: inflammatory signals gone awry in the p rimal response to stress [ J ]. J Leukoc Biol,2007, 82 (2) : 2042212.
8. Park JS, Gamboni2Robertson F, He Q, et al. High mobility group box 1 p rotein interacts with multip le Toll2like recep tors [ J ]. Am J Physiol Cell Physiol, 2006, 290 (3) : C917-C924.
9. Kalinowska-Herok M, Widlak P. High mobility group proteins stimulate DNA cleavage by apoptotic endonuclease DFF40/CAD due to HMG-box interactions with DNA [J]. Acta Biochim Pol, 2008, 55(1): 21-26.
10. Herold K, Moser B, Chen Y, et al. Receptor for advanced glycation end products(RAGE) in a dash to the rescue: inflammatory signals gone awry in the primal response to stress [J]. J Leukoc Biol, 2007, 82 (2) : 204-212.
11. Kokkola R , Andersson A , Mullins G, et al . RAGE is t he major receptor for the proinflammatory activity of HMGB1 in rodent macrophages. Scand J Immunol ,2005,61(1):1-9.
12. Chen G, Ward MF , Sama AE , et al . Extracellular HMGB1 as a proinflammatory cytokine. J Interferon Cytokine Res ,2004,24(6):329-333.
13. Park J S , Svet kauskaite D , He Q , et al . Involvement of toll-like receptors 2and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem ,2004,297(9):7370-7377.
14. Dumitriu I E ,Baruah P ,Valentinis B et al . Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products[J ] . J Immunol ,2005 ;174 :7506-7515.
15. Jiang W,Pisetsky D S. Mechanisms of Disease :the role of high mobility group protein 1 in the pathogenesis of inflammatory arthritis[J ] . Nat Clin Pract Rheumatol ,2007 ;3 (1) :52258.
16. Andersson U, Wang H, Palmblad K, et al. High mobility group -1 protein (HMG-1 ) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med,,2000,192(4):565-570.
17. Park JS, Arcaroli J, Yum HK, et al. Activation of gene expression in human neutrophils by high mobility group box 1 protein. Am J Physiol Cell Physiol,,2003,284(4):870-879.
18. MessmerD, Yang H, Telusma G, et al. High mobility group box protein1: an endogenous signal for dendritic cell maturation and Th1 polarization. J Immunol,2004,173(4):307-313.
19. Rendon Mitchell B, OchaniM, Li J, et al1 IFN-γinduces high mobility group box 1 protein release partly through a TNF-αdependent mechanism. J Immunol,2003,170(7);3890-3897.
20. DeMarco RA, Fink MP, Lotze MT. Monocytes promote natural killer cell interferon gamma production in response to the endogenous danger signal HMGB1. Mol Immunol, 2005, 42 (4) : 433-444.
21.Yang H, OchaniM, Li J, et al1 Reversing established sepsis with antagonists of endogenous high2mobility group box 1[J]1 Proc Natl Acad Sci USA, 2004, 101 ( 1) : 296-301
22. Lotze MT, Tracey KJ1 High2mobility group box 1 protein(HMGB1) : nuclear weapon in the immune arsenal [ J ] Nat Rev Immunol, 2005, 5 ( 4) : 331-342
23. Kim JY, Park JS, Strassheim D, et al1 HMGB1 contributes to the development of acute lung injury after hemorrhage[ J ]1 Am J Physiol Lung CellMol Physiol, 2005, 288 ( 5) :958-965
24. Mantell LL, ParrishWR, Ulloa L. HMGB21 as a therapeutic target for infectious and inflammatory disorders [ J ] Shock, 2006, 25 ( 1) : 4-11
25杨廷芳,王兴勇,胡语航,等. NF-κB和HMGB1在大鼠肠缺血再灌注肺损伤中的表达及白藜芦醇苷的保护作用[J].重庆医科大学学报,2009,34(1):24-28.
26. Kim J Y,Park J S,Strassheim D,et al. HMGB1 contributes to the development of acute lung injury after hemorrhage[J]. AmJ Physiol Lung Cell Mol Physiol,2005,288(5):L958-L965.
27.杨智勇,陶京,周峰,等.高迁移率族蛋白1对多形核白细胞粘附和游出肺毛细血管内皮细胞的影响及其机制[J]。世界华人消化杂志,2007,15(22):2403-2407.
28. Gang Liu, Jing Wang1, Young-Jun Park,et al. HMGB1 inhibits phagocytosis of apoptotic neutrophils through binding to phosphatidylserine [J]. Immunol, 2008 ,181(6): 4240–4246.
29. Guan-Hong Shang, Dian-Jie Lin, Wei Xiao. Ethyl pyruvate reduces mortality in anendotoxin-induced severe acute lung injury mouse model [J]. Respiratory Research ,2009, 10(91):1-7.
30. Marieke A.D. van Zoelen, Akitoshi Ishizaka, Esther K. Wolthuis, et al.Pulmonary levels of High-mobility group box 1 during mechanical ventilation and ventilator-associated pneumonia [J].shock, 2008,29(4):441-445.
31. Gong Q, Xu JF , Yin H,et al. Protective Effect of Antagonist of High-mobility Group Box 1 on Lipopolysaccharide-Induced Acute Lung Injury in Mice [J]. Scandinavian Journal of Immunology ,2009,69(1):29–35.
32. Volp K, BrezniceanuML, Bosser S, et al. Increased exp ression of high mobility group box 1 is associated with an elevated level of anti-apototic c-IAP2 p rotein in human colon carcinomas [ J ]. Gut,2006, 55 (2) : 234-242.
33. Ellerman JE, Brown CK, de Vera M, et al. Masquerader: high mobility group box-1 and cancer [ J ]. Clin Cancer Res, 2007, 139(10) : 2836-2848.
34. Dumitriu IE, Baruah P, Manfredi AA, Bianchi ME, Rovere-Querini P. HMGB1: guiding immunity from within. Trends Immunol 2005;26:381e7.
35. Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002;418:191e5.
36. Rovere-Querini P, Capobianco A, Scaffidi P, Valentinis B,Catalanotti F, Giazzon M, et al. HMGB1 is an endogenous immune adjuvant released by necrotic cells. EMBO Rep 2004;5:825e30.
37. Huttunen HJ, Fages C, Rauvala H. Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways. J Biol Chem 1999;274:19919e24.
38.. Taguchi A, Blood DC, del Toro G, Canet A, Lee DC, Qu W, et al.Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature 2000;405:354e60.
39. Park JS, Gamboni-Robertson F, He Q, Svetkauskaite D, Kim JY,Strassheim D, et al.High mobility group box 1 protein interacts with multiple Toll-like receptors. Am J Physiol Cell Physiol2006;290:C917e24.
40.Yan SF, Ramasamy R, Schmidt AM. Receptor for AGE (RAGE) and its ligands-cast into leading roles in diabetes and the inflammatory response [J]. J Mol Med, 2009, 87(3): 235-247.
41.刘懿张鹏吴志浩等. RNA干扰抑制HMGB1基因表达对肺癌细胞L9981增殖和侵袭的影响[J].中国肺癌杂志,2009,12(6):549-554.
42. Guan-Hong Shang , Chong-Qi Jia ,Hui Tian,et al. Serum high mobility group box protein 1 as a clinical marker for non-small cell lung cancer [J]. Respiratory Medicine ,2009,103(12):1949-1953.
43.徐圣葆,梅晓冬. HMGB1、VEGF2C在肺癌组织中的表达及临床意义[J].山东医药,2009,49(12):50-51.
44. Lim SC, Choi JE, Kim CH, et al.Ethyl pyruvate induces necrosis-to-apoptosis switch and inhibits high mobility group box protein 1 release in A549 lung adenocarcinoma cells r[J]. Int J Mol Med ,2007,20(2):187-192.
45. Naoki Hamada, Takashige Maeyama, Tomonobu Kawaguchi,et al. The Role of High Mobility Group Box1 in Pulmonary Fibrosis [J]. American Journal of Respiratory Cell and Molecular Biology, 2008,39(4):440-447.
46. Rowe SM, Jackson PL,Liu G,et al. Potential Role of High-Mobility Group Box 1 in Cystic Fibrosis Airway Disease [J].Am J Respir Crit Care Med,2008,178(8):822-831.
47. Kakizaki T, Kohno M, Watenabe M, et al.Exacerbation of Bleomycin-Induced Injury and Fibrosis by Pneumonectomy in the Residual Lung of Mice[J]. Journal of Surgical Research ,2009,154(2):336–344 .
48. Van Zoelen MA, Laterre PF, Van Veen SQ, et al. Systemic and local high mobility group box 1 concentrations during severe infection [J]. Crit Care Med,2007,35(12):2799-2804.
49. Angus DC,Yang L,Kong L,et al. Circulating high-mobility group box 1 (HMGB1) concentrations are elevated in both uncomplicated pneumonia and pneumonia with severe sepsis[J]. Crit Care Med,2007,35(4):1061-1067.
50. Kosai K,Seki M,Yanagihara K,et al. Elevated levels of high mobility group box chromosomal protein-1 (HMGB-1) in sera from patients with severe bacterial pneumonia coinfected with influenza virus[J]. Scand J Infect Dis , 2008 ,40(4):338-342.
51. Bowler RP. Oxidative stress in the pathogenesis of asthma[ J] . Curr Allergy Asthma Rep, 2004, 4(2):116-22.
52. Wu J, Kobayashi M, Sousa EA, et al. Differential proteomic analysis of bronchoalveolar lavage fluid in asthmatics following segmental antigen challenge[ J] . Mol Cell Proteomics, 2005, 4(9): 1251-64.
53.付亮,蔡绍曦,赵海金等. N-乙酰半胱氨酸对哮喘小鼠肺组织HMGB1、RAGE表达的影响[J].南方医科大学学报,2008,28(5):692-699.
54. Taira T,Matsuyama W, Mitsuyama H,et al. Increased serum high mobility group box-1 level in churg-strauss syndrome[J].clinical and Experimental Immunology,2007,148(2):241-247.
2. Cosio MG,Hale KA ,Niewoehner M,et al . Morphologic and morphometric effects of prolonged cigarette smoking on the small airways[J ] . Am Rev Respir Dis ,1980 ,122 (2) :205～221.
3.马鸿达,张乃鑫,赵天如,等.吸烟者肺泡接触段破坏及其小气道形态异常的关系[J ] .中华病理学杂志,1996 ,25 (4) :216～219.
4.马鸿达,张乃鑫,祝尔诚.吸烟肺小气道形态计量学及其与肺气肿类型的关系[J ] .天津医学,1995 ,23 (8) :451～455.
5.叶任高.内科学[M ] .第5版.北京:人民卫生出版社, 2001. 15- 18.
6.周汉良,陈季强.呼吸药理学与治疗学[M ].北京:人民出版社,1998: 912.
7. Hansel TT, Barnes PJ. New D rugs fo r A sthma, A llergy and COPD [M ]. Basel: ProgRespir Res, 2001: 160 - 164.
8. Thorburn J, Frankel AE, Thorburn A. Regulation of HMGB1 release by autophagy. Autophagy, 2009, 5: 247-249.
9. Bustin M, Lehn DA, Landsman D. Structural features of the HMG chromosomal proteins and their genes. Biochim Biophys Acta 1990;1049:231e43.
10.Andersson U, Erlandsson-Harris H, Yang H, Tracey KJ. HMGB1 asa DNA-binding cytokine. J Leukoc Biol 2002;72:1084e91.
11. Wang H , Bloom O , Zhang M , et al . HMGB1 as a late mediator of endotoxin lethality in mice. Science , 1999 , 285 (5425) : 248-251.
12. Stros M, Bacikova A, Polanska E, et al.HMGB1 interacts with humantopoisomerase IIalpha and stimulates its catalytic activity [J].NucleicAcids Res, 2007, 35(15): 50013.
13. Coffey JC,Wang JH, Kelly R, et al.Tolerization with BLP down- regulates HMGB1 a critical mediator of sepsis- related lethality [J]. JLeukoc Biol, 2007, 82(4): 906.
14. Holmlund U,Wahamaa H, Bachmayer N, et al.The novel inflammatory cytokine high mobility group box protein 1 (HMGB1) is expressed by human term placenta[J].Immunology, 2007, 122(3):430.
15. Rauvala H, Rouhiainen A. RAGE as a recep tor of HMGB1 (Am-photerin) : roles in health and disease [ J ]. CurrMolMed, 2007, 7(8) : 725-734.
16. Yang H,Wang H, Czura CJ, et al. The cytokine activity of HMGB1[ J ]. J Leukoc Biol, 2005, 78 (1) : 128
17. Bianchi ME , Manf redi AA. High2mobility group box 1( HMGB1) protein at t he crossroads between innate and adaptive immunity [J ] . Immunol Rev , 2007 ,220 : 35246.
18. BianchiME, Manfredi AA. Immunology. Dangers in and out[ J ]. Science, 2009, 323 (5922) : 1683 - 1684.
19. Klune JR, Dhupar R, Cardinal J , et al. HMGB1: endogenous danger signaling[ J ]. MolMed, 2008, 14 (7 - 8) : 476- 484.
20. Karlsson S, Pettil?V, Tenhunen J , et al. HMGB1 as apredictor of organ dysfunction and outcome in patientswith severe sepsis[ J ]. Intensive CareMed, 2008, 34 (6) : 1046-1053.
21. Abraham E, Arcaroli J, CarmodyA, et al. HMG21 as a mediator of acute lung Inflammation [ J ]. The Journal of Immunology, 2000,165 (6) : 2950-2924.
22. Kokkola R,Andersson A,Mullins G, et al. RAGE is the major recep tor for the p roinflammatory activity of HMGB1 in rodentmacrophages[ J ]. Scand Immunol, 2005, 61 (1) : 129.
23. Orlova VV, Choi EY, Xie CP, et al. A novel pathway of HMGB1 mediated inflammatory cell recruitment that requiresMac-1-integrin[ J ]. EMBO, 2007, 26 (4) : 112921139.
24. Fan J, Li Y, Levy RM, et al. Hemorrhagic shock induces NAD ( P) H oxidase activation in neutrophils: role of HMGB1-TLR4signaling[ J ]. J Immunol, 2007, 178 (10) : 657326580.
25. Yang H , Wang H , Czura CJ , et al . The cytokine activity of HMGB1. J Leukoc Biol , 2005 , 78 (1) : 128.
26. Gong Q, Xu JF , Yin H, et al. Protective Effect of Antagonist of High-mobility Group Box 1 on Lipopolysaccharide-Induced Acute Lung Injury in Mice[J]. Scandinavian Journal of Immunology ,2009,69(1):29–35.
27. Guan-Hong Shang , Chong-Qi Jia ,Hui Tian,et al. Serum high mobility group box protein 1 as a clinical marker for non-small cell lung cancer [J]. Respiratory Medicine ,2009,103(12):1949-1953.
28. KakizakiT, Kohno M, Watenabe M, et al.Exacerbation of Bleomycin-Induced Injury and Fibrosis by Pneumonectomy in the Residual Lung of Mice[J]. Journal of Surgical Research ,2009,154(2):336–344 .
29. Ferhani N, Letuve S, Kozhich A, et al. Expression of high-mobility group box 1 and of receptor for advanced glycation end products in chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 2010,181(9):917-927.
30. Karlsson S ,Pettil?V ,Tenhunen J ,et al . HMGB1 as a predictor of organ dysfunction and outcome in patients with severe sepsis[J ] . Intensive Care Med ,2008 ,34 (6) :1046.
31.陈国千,胡志刚,王春新,等.外科术后患者血清HMGB1水平的变化及其意义[J] .中华临床医师杂志(电子版) ,2009 ,3 (3) :478.
32.曾玉兰,杨荣时,彭红星.盐酸氨溴索对吸烟诱导的支气管炎大鼠MIP- 2的影响[J].中国现代医学杂,2009,19(17):2585-2587.
33.李莉,王向东.糖皮质激素抑制慢性支气管炎大鼠气道磷酸二酯酶4D和肿瘤坏死因子α的表达[J].中国呼吸与危重监护杂志,2009,8(6):534-538.
34.冯正仪主编.内科护理学[M ].上海:上海科学技术出版社,2002: 9, 12.
35. Sherrill DL, Holberg CJ, Enright PL, et al. Longitudinal analysis of the effects of smoking onset and cessation on pulmonary function.Am J Resp ir Crit CareMed, 1994, 149: 591-597.
36.邬强珍.浅谈老年慢性支气管炎病人的健康教育指导[ J ].中国全科医学, 1999, 2 (4) :321.
37.潭壮生.吸烟和饮酒现状及其危害和对策[J].中国全科医学, 2006 ,9(13):1082-1084.
38.Zhang H ,Cai B. The impact of tobacco on lung health in China Respirology ,2003 ,8 :17-21.
39.李爱兰,黄悦勤,王燕玲,等.我国青少年吸烟行为及其影响因素的初步分析[J].中国公共卫生, 2001, 17(1): 75-77.
40.杨功焕. 1996年全国吸烟行为的流行病学调查[M].北京:中国科学技术出版社, 1997: 17-18.
41. D'Armiento J, Dalal SS, Okada Y, et al. Collagenase exprssion in the lungs of transgenic mice cause pulmonary emphysema. Cell 1992;71(6):955-961.
42. Chung KF. Inflammatory mediators in chronic obstructive pulmonary disease. Curr Drug Targets Inflamm Allergy 2005;4(6):619-625
43. Chung KF. Cytokines as targets in chronic obstructive pulmonary disease. Curr Drug Targets 2006;7(6):675-681
44. Chung KF. Cytokine in chronic obstructive pulmonary disease. Eur Respir J Suppl 2001;34:50s-59s
45. Stockley RA. Neutrophils and the pathogenesis of COPD. Chest 2002 ;121(5uppl):151s-155s
46. Hallberg J, Dominicus A, Eriksson UK,et al. Interaction Between Smoking andGenetic Factors in the Development of Chronic Bronchitis.Am J Respir Crit Care Med 2007; 2008;177(5):486-490.
47. Hasegawa M,Nasuhara Y,Onodera Y,et al . Airflow limitation and airway dimensions in chronic obstructive pulmonary disease[J ] . AmJ Respir Crit Care Med ,2006 ,173 (12) :1309 - 1315.
48. Ellerman JE, Brown CK, de Vera M, et al. Masquerader: high mobility group box-1 and cancer [ J ]. Clin Cancer Res, 2007, 139(10) : 2836-2848
49. MacNeeW, Donaldson K. Exacerbations of COPD: environmentalmechanisms [J]. Chest, 2000, 117 (5) : 390 -397.
50. MacNee W. Oxidants/Antioxidants and COPD. CHEST, 2000, 117:303-317.
51. Barnes PJ, Shap iro SD, PauwelsRA. Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Resp ir J, 2003, 22:672-688.
52.李庆云,黄绍光,吴华成,等.大鼠吸烟致慢性支气管炎模型气道炎症研究[J].上海第二医科大学学报, 2004, 1: 31.
53.王慧,程德云,张永,等.单核细胞趋化蛋白1在熏香烟大鼠气道表达及泼尼松对其的影响[ J ].中华结核和呼吸杂志, 2004, 27(7) : 490.
54. Dumit riu IE , Baruah P , Manf redi AA , et al . HMGB1 :guiding immunity from wit hin [ J ] . Trends Immunol ,2005 ,26 :3812387
55. Huttunen HJ , Rauvala H. Amphoterin as an extracellular regulator of cell motility: from discovery to disease[J ]. J InternM ed , 2004, 255 (3) : 351-366.
56. Bianchi ME , Manf redi AA. High-mobility group box 1( HMGB1) protein at the crossroads between innate and adaptive immunity [J] . Immunol Rev , 2007 ,220 : 35-46.
57.杨廷芳,王兴勇,胡语航. NF-κB和HMGB1在大鼠肠缺血再灌注肺损伤中的表达及白藜芦醇苷的保护作用.重庆医科大学学报,2009,34(1):24-28.
58. Yang H, OchaniM, Li J, et al1 Reversing established sepsis with antagonists of endogenous highmobility group box 1[ J ]1 Proc Natl Acad Sci USA, 2004, 101( 1) : 296-301.
59. Lotze MT, Tracey KJ1 High2mobility group box 1 protein(HMGB1) : nuclear weapon in the immune arsenal [ J ] .Nat Rev Immunol, 2005, 5 ( 4) : 331-342.
60. Pisetsky DS, Jiang W.Role of Toll- like receptors in HMGB1 release fromacrophages[J].Ann N Y Acad Sci, 2007, 1109:58.
61. Fossati S, Chiarugi A.Relevance of high- mobility group protein box 1 to neurodegeneration[J].Int Rev Neurobiol, 2007, 82: 137.
62. Kalinowska-Herok M, Widlak P. High mobility group proteins stimulate DNA cleavage by apoptotic endonuclease DFF40/CAD due to HMG-box interactions with DNA [J]. Acta Biochim Pol, 2008, 55(1): 21-26.
63. Herold K, Moser B, Chen Y, et al. Receptor for advanced glycation end products (RAGE) in a dash to the rescue: inflammatory signals gone awry in the primal response to stress [J]. J Leukoc Biol, 2007, 82 (2) : 204-212
64. Park JS, Svetkauskaite D, He Q, et al1 Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein1J Biol Chem, 2004, 279 (9) : 7370-7377
65. Gardella S, Andrei C, Ferrera D, Lotti LV, Torrisi MR, Bianchi ME,Rubartelli A. The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway. EMBO Rep 2002;3:995–1001.
66. Bonaldi T, Talamo F, Scaffidi P, Ferrera D, Porto A, Bachi A, Rubartelli A, Agresti A, Bianchi ME. Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. EMBO J 2003;22:5551–5560.
67. Park JS, Svetkauskaite D, He Q, Kim JY, Strassheim D, Ishizaka A,Abraham E. Involvement of Toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem 2004;279:7370–7377.
68.Lotze MT,Tracey KJ.High-mobility group box 1 protein (HMGB1):nuclearweaponin the immune arsenal.NatRevImmunol 2005;5:331–342.
69. Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature, 2002, 418(6894) :191-195
70 .Dumitriu I E ,Baruah P ,Valentinis B et al . Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products[J ] . J Immunol ,2005 ;174 :7506-7515.
71. Jiang W,Pisetsky D S. Mechanisms of Disease :the role of high mobility group protein 1 in the pathogenesis of inflammatory arthritis[J ] . Nat Clin Pract Rheumatol ,2007 ;3 (1) :52258.
72. Sha Y, Zmijewski J , Xu Z, et al. HMGB1 develops enhanced p roinflammatory activity by binding to cytokines[ J ]. J Immunol, 2008, 180 (4) : 2531 - 2537.
73. Park JS, Arcaroli J, Yum HK, Yang H, Wang H, Yang KY,Choe KH, Strassheim D, Pitts TM, Tracey KJ, Abraham E.Activation of gene expression in human neutrophils by high mobility group box 1 protein. Am J Physiol Cell Physiol 2003;284: C870-C879
74. Chen G, Ward MF , Sama AE , et al . Ext racellular HMGB1 as a proinflammatory cytokine. J Interferon Cytokine Res , 2004 , 24(6) : 329-333.
75. Andersson U, Wang H, Palmblad K, et al1High mobility group1 protein (HMG21 ) stimulates p roinflammatory cytokine synthesis in human monocytes1J Exp Med, 2000, 192 (4) : 565-5701.
76. Park JS, Arcaroli J, Yum HK, et al1Activation of gene exp ression in human neutrophils by high mobility group box 1 p rotein1Am J Physiol Cell Physiol, 2003, 284 (4) : C87028791
77. MessmerD, Yang H, Telusma G, et al1High mobility group box p rotein1:anendogenous signal for dendritic cell maturation and Th1 polarization1J Immunol, 2004, 173 (1) : 30723131
78. Czura C J , Tracey KJ . Targeting high mobility group box 1 as a late-acting mediator of inflammation. Crit Care Med , 2003 , 31 (1) : S46～50
79. Yang H , Wang H , Czura C J , Tracey KJ . HMGB1 as a cytokine and therapeutic target . J Endotoxin Res , 2002 , 8 (6) : 469～472
80. Andersson U , Erlandsson2Harris H , Yang H , Tracey KJ . HMGB1 as a DNA2binding cytokine. J Leukoctyte Biol , 2002 , 72 (6) :1084～1091
81.秦阳华,戴生明等.高迁移率族蛋白1促进巨噬细胞表达IL-18及其受体[J].第二军医大学学报,2009,30(12):1353-1356.
82. Klune JR, Dhupar R, Cardinal J, et al. HMGB1: endogenous danger signaling[ J ]. MolMed, 2008, 14: 4762484.
83. Degryse B, Virgilio M. The nuclear protein HMGB1, anew kind of chemokine ?. FEBS Lett, 2003, 553 (122):11-17.
84. Wang H , Ward MF, Fan XG, et al. Potential role of high mobility group box1 in viral infectious diseases . Viral Immunol, 2006, 19 (1) :3-9.
85. Lin X, Yang H, Sakuragi T, et al1 Alpha2chemokine recep tor blockade reduce high mobility group box 1 protein induced lung inflammation and injury and imp roves survivalin sepsis [ J ]1 Am J Physiol Lung CellMol Physiol, 2005,289 ( 4) : 583-590.
86. Yang H , Ochani M , Li J, et al. Reversing established sepsis with antagonists of endogenous high mobility group box 1. Proc Natl Acad Sci USA , 2004 , 101 (1) : 296-301.
87. Ulloa L , Ochani M Yang H, et al. Ethylpyruvate prevents lethality in mice with established lethal sepsis and systemic inflatammation.Proc Natl Acad Sci USA 2002,,9(19):12351-12356.
88. Zhi-Yong Yang, Yan Ling, Tao Yin,etl. Delayed ethylpyruvate therapy attenuates experimental severe acute pancreatitis vis reduced serum high mobility group box 1 levels in rats.World J Gastroenterol。2008,14(28):4546-4550.
89. Abraham E, Arcaroli J, CarmodyA, et al1 HMG21 as a mediator of acute lung inflammation [ J ] 1 J Immunol, 2000,165 ( 6) : 2950-2954
90. Gong Q, Xu JF , Yin H,et al. Protective Effect of Antagonist of High-mobility Group Box 1 on Lipopolysaccharide-Induced Acute Lung Injury in Mice [J]. Scandinavian Journal of Immunology ,2009,69(1):29–35.
91. Yasuda T, Ueda T, Takeyama Y, et al. Significant increase of serum high-mobility group box chromosomal p rotein 1 levels in patients with severe acute pancreatitis[ J ]. Pancreas, 2006, 33: 3592363.
92. Sawa H, Ueda T, Takeyama Y, et al. Blockade of high mobility group box-1 protein attenuates experimental severe acute pancreatitis [ J ].World J Gastroenterol, 2006, 12: 7666-7670.
93. Yang ZY,Ling Y, Yin T, et al. Delayed ethyl pyruvate therapy attenuates experimental severe acute pancreatitis via reduced serum high mobility group box
1 levels in rats [ J ]. World J Gastroenterol, 2008,14: 4546-4550.
94. Agnello D et al . Cytokine , 2002 , 18 (4) : 231—236
95. Abraham E et al . J Immunol , 2000 , 165 (6) : 2950—2954
96. Elwing J, Panos RJ. Pulmonary hypertension associated with COPD. Int J Chron Obstruct Pulmon Dis, 2008, 3(1): 55-70.
97. Wang H , Bloom O , Zhang M , et al . HMGB1 as a late mediator of endotoxin lethality in mice. Science , 1999 , 285 (5425) : 248-251.
98. Chen G, Ward MF , Sama AE , et al . Extracellular HMGB1 as a proinflammatory cytokine. Interferon Cytokine Res , 2004 , 24(6) : 329-333.
99. Taniguchi N , Kawahara K, Yone K, et al . High mobility group box chromosomal protein pay a role in the pathogenesis of rheumatoid as a novel cytokine.Arthritis Rheum,2003,48(4):971-981.
100 . Churg A, Zho u S, Wang X, et al. The role of interleukin-1beta in murine cigarette smoke-induced emphysema and small airway remodeling[J]. Am J Respir Cell Mol Biol,2009,40(4):482-490.
101. Dumit riu IE , Baruah P , Manf redi AA , et al . HMGB1 :guiding immunity f romwithin [J] . Trends Immunol ,2005 ,26(7) :381-387.
102. Wang H ,Ward MF , Fan XG,et al. Potential role of high mobility group box 1 in viral infectious diseases[J ] . Viral Immunol ,2006 ,19 (1) :3-9.
1. Wang H , Bloom O , Zhang M , et al . HMGB1 as a late mediator of endotoxin lethality in mice. Science , 1999 , 285 (5425) : 248-251.
2. Yang H , Wang H , Czura CJ , et al . The cytokine activity of H MGB1. J Leukoc Biol , 2005 , 78 (1) : 1-8.
3. Stros M, Bacikova A, Polanska E, et al.HMGB1 interacts with human topoisomerase IIalpha and stimulates its catalytic activity [J].Nucleic Acids Res, 2007, 35(15): 5001-5013.
4. Bianchi ME , Manf redi AA. High-mobility group box 1( HMGB1) protein at the crossroads between innate and adaptive immunity [J] . Immunol Rev , 2007 ,220 : 35-46.
5. Bianchi ME , Manf redi AA. High2mobility group box 1( HMGB1) protein at t he crossroads between innate and adaptive immunity [J ] . Immunol Rev , 2007 ,220 : 35-46.
6. Agnello D et al . Cytokine , 2002 , 18 (4) : 231—236
7. Herold K, MoserB, Chen Y, et al. Recep tor for advanced glycation end products (RAGE) in a dash to the rescue: inflammatory signals gone awry in the p rimal response to stress [ J ]. J Leukoc Biol,2007, 82 (2) : 2042212.
8. Park JS, Gamboni2Robertson F, He Q, et al. High mobility group box 1 p rotein interacts with multip le Toll2like recep tors [ J ]. Am J Physiol Cell Physiol, 2006, 290 (3) : C917-C924.
9. Kalinowska-Herok M, Widlak P. High mobility group proteins stimulate DNA cleavage by apoptotic endonuclease DFF40/CAD due to HMG-box interactions with DNA [J]. Acta Biochim Pol, 2008, 55(1): 21-26.
10. Herold K, Moser B, Chen Y, et al. Receptor for advanced glycation end products(RAGE) in a dash to the rescue: inflammatory signals gone awry in the primal response to stress [J]. J Leukoc Biol, 2007, 82 (2) : 204-212.
11. Kokkola R , Andersson A , Mullins G, et al . RAGE is t he major receptor for the proinflammatory activity of HMGB1 in rodent macrophages. Scand J Immunol ,2005,61(1):1-9.
12. Chen G, Ward MF , Sama AE , et al . Extracellular HMGB1 as a proinflammatory cytokine. J Interferon Cytokine Res ,2004,24(6):329-333.
13. Park J S , Svet kauskaite D , He Q , et al . Involvement of toll-like receptors 2and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem ,2004,297(9):7370-7377.
14. Dumitriu I E ,Baruah P ,Valentinis B et al . Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products[J ] . J Immunol ,2005 ;174 :7506-7515.
15. Jiang W,Pisetsky D S. Mechanisms of Disease :the role of high mobility group protein 1 in the pathogenesis of inflammatory arthritis[J ] . Nat Clin Pract Rheumatol ,2007 ;3 (1) :52258.
16. Andersson U, Wang H, Palmblad K, et al. High mobility group -1 protein (HMG-1 ) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med,,2000,192(4):565-570.
17. Park JS, Arcaroli J, Yum HK, et al. Activation of gene expression in human neutrophils by high mobility group box 1 protein. Am J Physiol Cell Physiol,,2003,284(4):870-879.
18. MessmerD, Yang H, Telusma G, et al. High mobility group box protein1: an endogenous signal for dendritic cell maturation and Th1 polarization. J Immunol,2004,173(4):307-313.
19. Rendon Mitchell B, OchaniM, Li J, et al1 IFN-γinduces high mobility group box 1 protein release partly through a TNF-αdependent mechanism. J Immunol,2003,170(7);3890-3897.
20. DeMarco RA, Fink MP, Lotze MT. Monocytes promote natural killer cell interferon gamma production in response to the endogenous danger signal HMGB1. Mol Immunol, 2005, 42 (4) : 433-444.
21.Yang H, OchaniM, Li J, et al1 Reversing established sepsis with antagonists of endogenous high2mobility group box 1[J]1 Proc Natl Acad Sci USA, 2004, 101 ( 1) : 296-301
22. Lotze MT, Tracey KJ1 High2mobility group box 1 protein(HMGB1) : nuclear weapon in the immune arsenal [ J ] Nat Rev Immunol, 2005, 5 ( 4) : 331-342
23. Kim JY, Park JS, Strassheim D, et al1 HMGB1 contributes to the development of acute lung injury after hemorrhage[ J ]1 Am J Physiol Lung CellMol Physiol, 2005, 288 ( 5) :958-965
24. Mantell LL, ParrishWR, Ulloa L. HMGB21 as a therapeutic target for infectious and inflammatory disorders [ J ] Shock, 2006, 25 ( 1) : 4-11
25杨廷芳,王兴勇,胡语航,等. NF-κB和HMGB1在大鼠肠缺血再灌注肺损伤中的表达及白藜芦醇苷的保护作用[J].重庆医科大学学报,2009,34(1):24-28.
26. Kim J Y,Park J S,Strassheim D,et al. HMGB1 contributes to the development of acute lung injury after hemorrhage[J]. AmJ Physiol Lung Cell Mol Physiol,2005,288(5):L958-L965.
27.杨智勇,陶京,周峰,等.高迁移率族蛋白1对多形核白细胞粘附和游出肺毛细血管内皮细胞的影响及其机制[J]。世界华人消化杂志,2007,15(22):2403-2407.
28. Gang Liu, Jing Wang1, Young-Jun Park,et al. HMGB1 inhibits phagocytosis of apoptotic neutrophils through binding to phosphatidylserine [J]. Immunol, 2008 ,181(6): 4240–4246.
29. Guan-Hong Shang, Dian-Jie Lin, Wei Xiao. Ethyl pyruvate reduces mortality in anendotoxin-induced severe acute lung injury mouse model [J]. Respiratory Research ,2009, 10(91):1-7.
30. Marieke A.D. van Zoelen, Akitoshi Ishizaka, Esther K. Wolthuis, et al.Pulmonary levels of High-mobility group box 1 during mechanical ventilation and ventilator-associated pneumonia [J].shock, 2008,29(4):441-445.
31. Gong Q, Xu JF , Yin H,et al. Protective Effect of Antagonist of High-mobility Group Box 1 on Lipopolysaccharide-Induced Acute Lung Injury in Mice [J]. Scandinavian Journal of Immunology ,2009,69(1):29–35.
32. Volp K, BrezniceanuML, Bosser S, et al. Increased exp ression of high mobility group box 1 is associated with an elevated level of anti-apototic c-IAP2 p rotein in human colon carcinomas [ J ]. Gut,2006, 55 (2) : 234-242.
33. Ellerman JE, Brown CK, de Vera M, et al. Masquerader: high mobility group box-1 and cancer [ J ]. Clin Cancer Res, 2007, 139(10) : 2836-2848.
34. Dumitriu IE, Baruah P, Manfredi AA, Bianchi ME, Rovere-Querini P. HMGB1: guiding immunity from within. Trends Immunol 2005;26:381e7.
35. Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002;418:191e5.
36. Rovere-Querini P, Capobianco A, Scaffidi P, Valentinis B,Catalanotti F, Giazzon M, et al. HMGB1 is an endogenous immune adjuvant released by necrotic cells. EMBO Rep 2004;5:825e30.
37. Huttunen HJ, Fages C, Rauvala H. Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways. J Biol Chem 1999;274:19919e24.
38.. Taguchi A, Blood DC, del Toro G, Canet A, Lee DC, Qu W, et al.Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature 2000;405:354e60.
39. Park JS, Gamboni-Robertson F, He Q, Svetkauskaite D, Kim JY,Strassheim D, et al.High mobility group box 1 protein interacts with multiple Toll-like receptors. Am J Physiol Cell Physiol2006;290:C917e24.
40.Yan SF, Ramasamy R, Schmidt AM. Receptor for AGE (RAGE) and its ligands-cast into leading roles in diabetes and the inflammatory response [J]. J Mol Med, 2009, 87(3): 235-247.
41.刘懿张鹏吴志浩等. RNA干扰抑制HMGB1基因表达对肺癌细胞L9981增殖和侵袭的影响[J].中国肺癌杂志,2009,12(6):549-554.
42. Guan-Hong Shang , Chong-Qi Jia ,Hui Tian,et al. Serum high mobility group box protein 1 as a clinical marker for non-small cell lung cancer [J]. Respiratory Medicine ,2009,103(12):1949-1953.
43.徐圣葆,梅晓冬. HMGB1、VEGF2C在肺癌组织中的表达及临床意义[J].山东医药,2009,49(12):50-51.
44. Lim SC, Choi JE, Kim CH, et al.Ethyl pyruvate induces necrosis-to-apoptosis switch and inhibits high mobility group box protein 1 release in A549 lung adenocarcinoma cells r[J]. Int J Mol Med ,2007,20(2):187-192.
45. Naoki Hamada, Takashige Maeyama, Tomonobu Kawaguchi,et al. The Role of High Mobility Group Box1 in Pulmonary Fibrosis [J]. American Journal of Respiratory Cell and Molecular Biology, 2008,39(4):440-447.
46. Rowe SM, Jackson PL,Liu G,et al. Potential Role of High-Mobility Group Box 1 in Cystic Fibrosis Airway Disease [J].Am J Respir Crit Care Med,2008,178(8):822-831.
47. Kakizaki T, Kohno M, Watenabe M, et al.Exacerbation of Bleomycin-Induced Injury and Fibrosis by Pneumonectomy in the Residual Lung of Mice[J]. Journal of Surgical Research ,2009,154(2):336–344 .
48. Van Zoelen MA, Laterre PF, Van Veen SQ, et al. Systemic and local high mobility group box 1 concentrations during severe infection [J]. Crit Care Med,2007,35(12):2799-2804.
49. Angus DC,Yang L,Kong L,et al. Circulating high-mobility group box 1 (HMGB1) concentrations are elevated in both uncomplicated pneumonia and pneumonia with severe sepsis[J]. Crit Care Med,2007,35(4):1061-1067.
50. Kosai K,Seki M,Yanagihara K,et al. Elevated levels of high mobility group box chromosomal protein-1 (HMGB-1) in sera from patients with severe bacterial pneumonia coinfected with influenza virus[J]. Scand J Infect Dis , 2008 ,40(4):338-342.
51. Bowler RP. Oxidative stress in the pathogenesis of asthma[ J] . Curr Allergy Asthma Rep, 2004, 4(2):116-22.
52. Wu J, Kobayashi M, Sousa EA, et al. Differential proteomic analysis of bronchoalveolar lavage fluid in asthmatics following segmental antigen challenge[ J] . Mol Cell Proteomics, 2005, 4(9): 1251-64.
53.付亮,蔡绍曦,赵海金等. N-乙酰半胱氨酸对哮喘小鼠肺组织HMGB1、RAGE表达的影响[J].南方医科大学学报,2008,28(5):692-699.
54. Taira T,Matsuyama W, Mitsuyama H,et al. Increased serum high mobility group box-1 level in churg-strauss syndrome[J].clinical and Experimental Immunology,2007,148(2):241-247.